News|Articles|August 1, 2024
Scalable Solutions for Novel Oral Solid Dose Development and Manufacturing
Author(s)Alcami
Developing successful oral solid dosage forms necessitates partnering with a CDMO equipped with distinctive technologies and expertise to enable support across solid-state characterization, formulation development and scale-up manufacturing processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
